28151486|t|Star-PAP, a poly(A) polymerase, functions as a tumor suppressor in an orthotopic human breast cancer model.
28151486|a|Star-PAP is a noncanonical poly(A) polymerase and required for the expression of a select set of mRNAs. However, the pathological role of Star-PAP in cancer largely remains unknown. In this study, we observed decreased expression of Star-PAP in breast cancer cell lines and tissues. Ectopic Star-PAP expression inhibited proliferation as well as colony-forming ability of breast cancer cells. In breast cancer patients, high levels of Star-PAP correlated with an improved prognosis. Moreover, by regulating the expression of BIK (BCL2-interacting killer), Star-PAP induced apoptosis of breast cancer cells through the mitochondrial pathway. The growth of breast cancer xenografts in NOD/SCID mice was also inhibited by the doxycycline-induced Star-PAP overexpression. Furthermore, Star-PAP sensitized breast cancer cells to chemotherapy drugs both in vitro and in vivo. In mammary epithelial cells, Star-PAP knockdown partially transformed these cells and induced them to undergo epithelial-mesenchymal transition (EMT). These findings suggested that Star-PAP possesses tumor-suppressing activity and can be a valuable target for developing new cancer therapeutic strategies.
28151486	0	8	Star-PAP	GeneOrGeneProduct	64852
28151486	12	30	poly(A) polymerase	GeneOrGeneProduct	64852
28151486	47	52	tumor	DiseaseOrPhenotypicFeature	D009369
28151486	81	86	human	OrganismTaxon	9606
28151486	87	100	breast cancer	DiseaseOrPhenotypicFeature	D001943
28151486	108	116	Star-PAP	GeneOrGeneProduct	64852
28151486	135	153	poly(A) polymerase	GeneOrGeneProduct	64852
28151486	246	254	Star-PAP	GeneOrGeneProduct	64852
28151486	258	264	cancer	DiseaseOrPhenotypicFeature	D009369
28151486	341	349	Star-PAP	GeneOrGeneProduct	64852
28151486	353	366	breast cancer	DiseaseOrPhenotypicFeature	D001943
28151486	399	407	Star-PAP	GeneOrGeneProduct	64852
28151486	480	493	breast cancer	DiseaseOrPhenotypicFeature	D001943
28151486	504	517	breast cancer	DiseaseOrPhenotypicFeature	D001943
28151486	518	526	patients	OrganismTaxon	9606
28151486	543	551	Star-PAP	GeneOrGeneProduct	64852
28151486	633	636	BIK	GeneOrGeneProduct	638
28151486	638	661	BCL2-interacting killer	GeneOrGeneProduct	638
28151486	664	672	Star-PAP	GeneOrGeneProduct	64852
28151486	694	707	breast cancer	DiseaseOrPhenotypicFeature	D001943
28151486	763	776	breast cancer	DiseaseOrPhenotypicFeature	D001943
28151486	795	799	SCID	DiseaseOrPhenotypicFeature	D016511
28151486	800	804	mice	OrganismTaxon	10090
28151486	831	842	doxycycline	ChemicalEntity	D004318
28151486	851	859	Star-PAP	GeneOrGeneProduct	64852
28151486	889	897	Star-PAP	GeneOrGeneProduct	64852
28151486	909	922	breast cancer	DiseaseOrPhenotypicFeature	D001943
28151486	1007	1015	Star-PAP	GeneOrGeneProduct	64852
28151486	1159	1167	Star-PAP	GeneOrGeneProduct	64852
28151486	1178	1183	tumor	DiseaseOrPhenotypicFeature	D009369
28151486	1253	1259	cancer	DiseaseOrPhenotypicFeature	D009369
28151486	Association	D004318	D016511	No
28151486	Negative_Correlation	D004318	D001943	No
28151486	Positive_Correlation	D004318	64852	No
28151486	Association	638	D001943	No
28151486	Association	638	64852	No
28151486	Association	64852	D016511	No
28151486	Association	64852	D001943	Novel
28151486	Negative_Correlation	64852	D009369	Novel